Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc. is a security (CUSIP 007CVR020) tracked across SEC portfolio filings. 1 registered fund positions totaling $237K via N-PORT as of 2026-03-31.

Summary

• Issuer: Spyre Therapeutics, Inc.
• CUSIP: 007CVR020
• Asset category: EC
• 13F holders: 0
• N-PORT fund positions: 1
• N-PORT value: $237K
• N-PORT report: 2026-03-31

Top fund holders (N-PORT)

More

• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search